FDA Issues Five Warning Letters to Makers of Knockoff GLP-1 Drugs
By EsqSocial Corporation 20/12/24
On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of the five warning letters were to companies (specifically, Xcel Research, Prime Vitality, Summit Research Peptides, and Swisschem) that claimed to distribute GLP-1s “for research use only” in spite of ample evidence to the contrary. The fifth, issued to Verony, was based on its manufacturing and distribution of oral GLP-1s that it falsely claimed were approved by FDA....
By: Fuerst Ittleman David & Joseph